A pilot clinical study to evaluate the safety and effectiveness of nutritional supplement Supply6 360 in improving gastrointestinal health and wellness. - NI

Kanari Nutrition Pvt. Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1.Healthy male and females between 25-35 years of age both inclusive. 2.BMI between 18.5 – 29.9 kg/m2. 3.Subjects should self-report at least two of the following gastrointestinal symptoms: epigastric discomfort, heartburn, bloating, nausea, fullness in the stomach, abdominal pain, or anorexia. 4.Not consuming probiotics, prebiotics, etc. 5.Subjects must demonstrate their willingness to participate in the study and comply with its procedures by signing a written informed consent.

•1.Participants with major abdominal surgery a history of inflammatory bowel disease or diverticular disease celiac disease allergic diseases including asthma psychiatric disorders and critical systemic illness as assessed by medical history appropriate consultations and laboratory tests
•2.Actively having a gut infection
•3.History of or complications from malignant tumors
•4.Females who are pregnant and have a positive urine pregnancy test planning to be pregnant/lactating or not using reliable methods of contraception
•5.Participants with heavy alcohol consumption or smoking or tobacco consumption
•6.Any condition that could in the opinion of the investigator preclude the participants ability to complete the study or that may confound study outcomes.

发起方

Kanari Nutrition Pvt. Ltd.